Exagen Inc Stock Price on December 16, 2024
| XGN Stock | USD 5.15 0.44 9.34% |
Below is the normalized historical share price chart for Exagen Inc extending back to September 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Exagen stands at 5.15, as last reported on the 21st of December, with the highest price reaching 5.18 and the lowest price hitting 4.72 during the day.
If you're considering investing in Exagen Stock, it is important to understand the factors that can impact its price. Exagen appears to be unstable, given 3 months investment horizon. Exagen Inc secures Sharpe Ratio (or Efficiency) of 0.16, which denotes the company had a 0.16% return per unit of standard deviation over the last 3 months. By reviewing Exagen's technical indicators, you can evaluate if the expected return of 0.98% is justified by implied risk. Please utilize Exagen's Mean Deviation of 4.53, downside deviation of 4.47, and Semi Deviation of 3.91 to check if our risk estimates are consistent with your expectations.
At this time, Exagen's Common Stock Shares Outstanding is very stable compared to the past year. As of the 21st of December 2024, Stock Based Compensation is likely to grow to about 3.8 M, while Total Stockholder Equity is likely to drop about 20.5 M. . As of the 21st of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 0.64. Exagen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of September 2019 | 200 Day MA 2.4837 | 50 Day MA 3.5452 | Beta 1.346 |
Exagen |
Sharpe Ratio = 0.1571
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | XGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.23 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.98 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Exagen is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Exagen by adding it to a well-diversified portfolio.
Price Book 7.045 | Enterprise Value Ebitda (0.16) | Price Sales 1.6031 | Shares Float 6.8 M | Wall Street Target Price 6.25 |
Related Headline
Psychemedics Headline on 12th of December 2024
Acquisition by Powell Anderson Capital Partners Llc of 30000... by Powell Anderson Capital Partners Llc
Filed transaction by Psychemedics 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Exagen Valuation on December 16, 2024
It is possible to determine the worth of Exagen on a given historical date. On December 16, 2024 Exagen was worth 6.15 at the beginning of the trading date compared to the closed value of 6.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Exagen stock. Still, in general, we apply an absolute valuation method to find Exagen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Exagen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Exagen's related companies.
| Open | High | Low | Close | Volume | |
| 6.00 | 6.15 | 5.73 | 5.78 | 248,865 | |
12/16/2024 | 6.15 | 6.22 | 5.84 | 6.00 | 313,174 |
| 6.02 | 6.07 | 5.60 | 5.80 | 196,543 |
| Backtest Exagen | | | Exagen History | | | Exagen Valuation | Previous | Next |
Exagen Trading Date Momentum on December 16, 2024
| On December 17 2024 Exagen Inc was traded for 5.80 at the closing time. Highest Exagen's price during the trading hours was 6.07 and the lowest price during the day was 5.60 . The net volume was 196.5 K. The overall trading history on the 17th of December 2024 contributed to the next trading period price depreciation. The trading price change to the next next day price was 3.33% . The overall trading delta to current price is 21.33% . |
Exagen Inc Fundamentals Correlations and Trends
By evaluating Exagen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Exagen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Exagen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Exagen Stock history
Exagen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Exagen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Exagen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Exagen stock prices may prove useful in developing a viable investing in Exagen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.7 M | 18.6 M | |
| Net Loss | -42.6 M | -40.5 M |
Exagen Quarterly Net Working Capital |
|
Exagen Stock Technical Analysis
Exagen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Exagen Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Exagen Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Exagen December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Exagen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Exagen shares will generate the highest return on investment. By undertsting and applying Exagen stock market strength indicators, traders can identify Exagen Inc entry and exit signals to maximize returns
Exagen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Exagen's price direction in advance. Along with the technical and fundamental analysis of Exagen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Exagen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1475 | |||
| Jensen Alpha | 1.04 | |||
| Total Risk Alpha | 0.8968 | |||
| Sortino Ratio | 0.2343 | |||
| Treynor Ratio | 0.9209 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Exagen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exagen. If investors know Exagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exagen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 3.163 | Quarterly Revenue Growth 0.066 | Return On Assets (0.17) | Return On Equity (0.70) |
The market value of Exagen Inc is measured differently than its book value, which is the value of Exagen that is recorded on the company's balance sheet. Investors also form their own opinion of Exagen's value that differs from its market value or its book value, called intrinsic value, which is Exagen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exagen's market value can be influenced by many factors that don't directly affect Exagen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exagen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exagen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exagen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.